Mary E. Wilson

Recent Advances and New Challenges in Travel Medicine.

Comparison of the post-transcriptional regulation of the mRNAs for the surface proteins PSA (GP46) and MSP (GP63) of Leishmania chagasi.

Biosynthesis of the major surface protease GP63 of Leishmania chagasi.

Leishmania chagasi: uptake of iron bound to lactoferrin or transferrin requires an iron reductase.

Illness after international travel.

Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection.

The sensitivity and specificity of Leishmania chagasi recombinant K39 antigen in the diagnosis of American visceral leishmaniasis and in differentiating active from subclinical infection.

The TGF-beta response to Leishmania chagasi in the absence of IL-12.

Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages.

Preventing infectious diseases during and after international adoption.

The major surface protease (MSP or GP63) of Leishmania sp. Biosynthesis, regulation of expression, and function.

Yellow Fever Immunizations: Indications and Risks.

Dermatologic Infectious Diseases in International Travelers.

Novel program of macrophage gene expression induced by phagocytosis of Leishmania chagasi.

Multiple products of the Leishmania chagasi major surface protease (MSP or GP63) gene family.

An emerging peri-urban pattern of infection with Leishmania chagasi, the protozoan causing visceral leishmaniasis in northeast Brazil.

Transmission of dengue virus without a mosquito vector: nosocomial mucocutaneous transmission and other routes of transmission.

Malaria Vaccine Trial: Modest Protection, Good Progress.

Internal and surface subpopulations of the major surface protease (MSP) of Leishmania chagasi.

Immunopathogenesis of infection with the visceralizing Leishmania species.

Regulation of genes encoding the major surface protease of Leishmania chagasi via mRNA stability.

Leishmania chagasi: the alpha-tubulin intercoding region results in constant levels of mRNA abundance despite protein synthesis inhibition and growth state.

Nosocomial dengue by mucocutaneous transmission.

Familial aggregation of mucosal leishmaniasis in northeast Brazil.

Diarrhea in nontravelers: risk and etiology.

Parenteral artesunate for treatment of severe malaria.

Role of caveolae in Leishmania chagasi phagocytosis and intracellular survival in macrophages.

IL6 -174 G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.

Clostridium difficile and childhood diarrhea: cause, consequence, or confounder.

Leishmania chagasi T-cell antigens identified through a double library screen.

Prevention of malaria in long-term travelers.

Oxidant generation by single infected monocytes after short-term fluorescence labeling of a protozoan parasite.

Nanostructured calcium phosphates (NanoCaPs) for non-viral gene delivery: influence of the synthesis parameters on transfection efficiency.

Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis.

Leishmania chagasi: a tetracycline-inducible cell line driven by T7 RNA polymerase.

Fever in returned travelers: results from the GeoSentinel Surveillance Network.

Controversies and misconceptions in malaria chemoprophylaxis for travelers.

Internal and surface-localized major surface proteases of Leishmania spp. and their differential release from promastigotes.

Leishmania chagasi: homogenous metacyclic promastigotes isolated by buoyant density are highly virulent in a mouse model.

Etiology of travel-related fever.

A function for a specific zinc metalloprotease of African trypanosomes.

Genetic predisposition to self-curing infection with the protozoan Leishmania chagasi: a genomewide scan.

An effect of parasite-encoded arginase on the outcome of murine cutaneous leishmaniasis.

The major surface protease (MSP or GP63) in the intracellular amastigote stage of Leishmania chagasi.

Alternative drug treatments for visceral leishmaniasis: miltefosine.

Alternative drug treatments for visceral leishmaniasis: paromomycin.

Different trans RNA splicing events in bloodstream and procyclic Trypanosoma brucei.

Yellow fever vaccines and international travelers.

Macrophage and T-cell gene expression in a model of early infection with the protozoan Leishmania chagasi.

A comparative analysis of methodological approaches used for estimating risk in travel medicine.

Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis.

Differential expression of a protease gene family in African trypanosomes.

Leishmania donovani ornithine decarboxylase is indispensable for parasite survival in the mammalian host.

Japanese encephalitis: new vaccines.

Threat of dengue to blood safety in dengue-endemic countries.

Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts.

Genetic admixture in Brazilians exposed to infection with Leishmania chagasi.

Differences in human macrophage receptor usage, lysosomal fusion kinetics and survival between logarithmic and metacyclic Leishmania infantum chagasi promastigotes.

Tick-borne rickettsiosis in traveler returning from Honduras.

Travel and the emergence of infectious diseases.

Illness in long-term travelers visiting GeoSentinel clinics.

Breastfeeding travelers: precautions and recommendations.

Sex and gender differences in travel-associated disease.

The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.

Leishmania infantum chagasi: a genome-based approach to identification of excreted/secreted proteins.

Dengue and chikungunya infections in travelers.

Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production.

Travel-associated dengue infections in the United States, 1996 to 2005. Letter 1.

Yellow fever virus transmission via breastfeeding: follow-up to the paper on breastfeeding travelers.

Vaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network.

Leukocytes infiltrate the skin and draining lymph nodes in response to the protozoan Leishmania infantum chagasi.

LXR deficiency confers increased protection against visceral Leishmania infection in mice.

Proteomic examination of Leishmania chagasi plasma membrane proteins: Contrast between avirulent and virulent (metacyclic) parasite forms.

Fabrication of circular microfluidic channels by combining mechanical micromilling and soft lithography.

Stage-specific pathways of Leishmania infantum chagasi entry and phagosome maturation in macrophages.

Study of parasite kinetics with antileishmanial drugs using real-time quantitative PCR in Indian visceral leishmaniasis.

The effects of macrophage source on the mechanism of phagocytosis and intracellular survival of Leishmania.

Serial quantitative PCR assay for detection, species-discrimination and quantification of Leishmania spp. in human samples.

Serial quantitative PCR assay for detection, species discrimination, and quantification of Leishmania spp. in human samples.

Mapping of VSG similarities in Trypanosoma brucei.

Latitudinal patterns of travel among returned travelers with influenza: results from the GeoSentinel Surveillance Network, 1997-2007.

Leishmania infantum chagasi in northeastern Brazil: asymptomatic infection at the urban perimeter.

Killed but metabolically active Leishmania as a novel whole-cell vaccine for visceral leishmaniasis.